Skip to main content
. 2022 Jun 14;11(12):e025862. doi: 10.1161/JAHA.121.025862

Table 3.

Primary and Secondary Outcomes

Outcome

Did not achieve predicted METs

(n=469)

Achieved predicted METs

(n=429)

Not transplanted

(n=223)

Transplanted*

(n=246)

Not transplanted

(n=150)

Transplanted*

(n=279)

MACE 42 (18%) 13 (5%) 14 (9%) 24 (9%)
Cardiac death 9 (4%) 3 (1%) 2 (1%) 7 (3%)
Non‐fatal MI 18 (8%) 8 (3%) 11 (7%) 12 (4%)
Stroke 15 (7%) 2 (1%) 1 (1%) 5 (2%)

MACE indicates major adverse cardiovascular event; METs, metabolic equivalents; and MI, myocardial infarction.

*

Transplantation was treated as a time‐dependent covariate.